Literature DB >> 31534657

Derivatives of a new heterocyclic system - pyrano[3,4-c][1,2,4]triazolo[4,3-a]pyridines: synthesis, docking analysis and neurotropic activity.

Ervand G Paronikyan1, Anthi Petrou2, Maria Fesatidou2, Athina Geronikaki2, Shushanik Sh Dashyan1, Suren S Mamyan1, Ruzanna G Paronikyan1, Ivetta M Nazaryan1, Hasmik H Hakopyan1.   

Abstract

8-Hydrazino derivatives of pyrano[3,4-c]pyridines and derivatives of the new heterocyclic system 3-thioxopyrano[3,4-c][1,2,4]triazolo[4,3-a]pyridines on the basis of methanesulfonates of pyrano[3,4-c]pyridinium were synthesized by optimization of a previously used method. Derivatives of alkylsulfonyl pyrano[3,4-c][1,2,4]triazolo[4,3-a]pyridines were also synthesized. All compounds were evaluated for their neurotropic activity. Among all the compounds tested for anticonvulsant activity by pentylenetetrazole and maximal electric shock seizure (MES) tests, six compounds (5a, 5b, 5e, 5g, 5j, and 5p) appeared to be active. These compounds were also evaluated for their anxiolytic as well as antidepressant activities using "open field", "elevated plus maze" (EPM), and "forced swimming" tests, respectively. It should be mentioned that compounds tested by the "rotating rod" method did not affect neuromuscular coordination. The most active compound appeared to be 5g in all tests. Docking studies of the most active compounds were performed on the GABAA receptor, SERT and 5-HT1A receptor.

Entities:  

Year:  2019        PMID: 31534657      PMCID: PMC6748274          DOI: 10.1039/c9md00187e

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  44 in total

1.  Design of new cognition enhancers: from computer prediction to synthesis and biological evaluation.

Authors:  Athina A Geronikaki; John C Dearden; Dmitrii Filimonov; Irina Galaeva; Taissia L Garibova; Tatiana Gloriozova; Valentina Krajneva; Alexey Lagunin; Fliur Z Macaev; Guenadij Molodavkin; Vladimir V Poroikov; Serghei I Pogrebnoi; Felix Shepeli; Tatiana A Voronina; Maria Tsitlakidou; Liudmila Vlad
Journal:  J Med Chem       Date:  2004-05-20       Impact factor: 7.446

Review 2.  Pharmacology of rapid-onset antidepressant treatment strategies.

Authors:  P Blier
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

3.  Design, synthesis, computational and biological evaluation of new anxiolytics.

Authors:  Athina Geronikaki; Eugeni Babaev; John Dearden; Wim Dehaen; Dmitrii Filimonov; Irina Galaeva; Valentina Krajneva; Alexey Lagunin; Fliur Macaev; Guenadiy Molodavkin; Vladimir Poroikov; Serghei Pogrebnoi; Victor Saloutin; Alla Stepanchikova; Eugenia Stingaci; Natalia Tkach; Liudmila Vlad; Tatiana Voronina
Journal:  Bioorg Med Chem       Date:  2004-12-15       Impact factor: 3.641

4.  Synthesis and evaluation of anti-inflammatory and analgesic activities of new 1,2,4-triazole derivatives.

Authors:  Fatemeh Ahmadi; Mohsen Rezayan Ghayahbashi; Mohammad Sharifzadeh; Eskandar Alipoiur; Seyed Nasser Ostad; Mohsen Vosooghi; Hamid Reza khademi; Mohsen Amini
Journal:  Med Chem       Date:  2014       Impact factor: 2.745

5.  Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor.

Authors:  Roberto Perrone; Francesco Berardi; Nicola A Colabufo; Enza Lacivita; Carmela Larizza; Marcello Leopoldo; Vincenzo Tortorella
Journal:  J Pharm Pharmacol       Date:  2005-10       Impact factor: 3.765

Review 6.  New avenues for anti-epileptic drug discovery and development.

Authors:  Wolfgang Löscher; Henrik Klitgaard; Roy E Twyman; Dieter Schmidt
Journal:  Nat Rev Drug Discov       Date:  2013-09-20       Impact factor: 84.694

7.  Evaluation of the elevated T-maze as an animal model of anxiety in the mouse.

Authors:  M C Jardim; R L Nogueira; F G Graeff; R L Nunes-de-Souza
Journal:  Brain Res Bull       Date:  1999-03-01       Impact factor: 4.077

Review 8.  Benzodiazepines in epilepsy: pharmacology and pharmacokinetics.

Authors:  J Riss; J Cloyd; J Gates; S Collins
Journal:  Acta Neurol Scand       Date:  2008-03-31       Impact factor: 3.209

Review 9.  The elevated T-maze as an experimental model of anxiety.

Authors:  F G Graeff; C F Netto; H Zangrossi
Journal:  Neurosci Biobehav Rev       Date:  1998       Impact factor: 8.989

10.  Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze.

Authors:  Alice Pulga; Chiara Ruzza; Anna Rizzi; Remo Guerrini; Girolamo Calo
Journal:  Eur J Neurosci       Date:  2012-08-29       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.